Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Other Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Other Equity
-$494k
CAGR 3-Years
47%
CAGR 5-Years
9%
CAGR 10-Years
6%
Johnson & Johnson
NYSE:JNJ
Other Equity
-$12.5B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
-9%
Bristol-Myers Squibb Co
NYSE:BMY
Other Equity
-$1.5B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Other Equity
-$7.8B
CAGR 3-Years
-12%
CAGR 5-Years
8%
CAGR 10-Years
-9%
Merck & Co Inc
NYSE:MRK
Other Equity
-$5.4B
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
-6%
Eli Lilly and Co
NYSE:LLY
Other Equity
-$4.3B
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
-5%

See Also

What is Nektar Therapeutics's Other Equity?
Other Equity
-494k USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Other Equity amounts to -494k USD.

What is Nektar Therapeutics's Other Equity growth rate?
Other Equity CAGR 10Y
6%

Over the last year, the Other Equity growth was 92%. The average annual Other Equity growth rates for Nektar Therapeutics have been 47% over the past three years , 9% over the past five years , and 6% over the past ten years .

Back to Top